Dogwood Therapeutics, Inc. SEC filings DWTX
Dogwood Therapeutics, Inc. has 328 filings in SEC EDGAR's recent list, going back to Jul 24, 2020. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (material agreement, unregistered share sale, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Oct 30, 2026 | — |
| S-3 | Shelf registration | Jan 15, 2026 | — |
| 424B5 | Prospectus supplement | Jan 13, 2026 | — |
| S-8 | Employee stock plan registration | Jan 8, 2026 | — |
| 424B5 | Prospectus supplement | Nov 28, 2025 | — |
| S-3/A | Filing | Oct 16, 2025 | — |
| S-3 | Shelf registration | Oct 1, 2025 | — |
| S-8 | Employee stock plan registration | Jun 26, 2025 | — |
| S-3 | Shelf registration | May 23, 2025 | — |
| 424B5 | Prospectus supplement | Mar 14, 2025 | — |
| 424B4 | Prospectus | May 20, 2024 | — |
| 424B4 | Prospectus | May 17, 2024 | — |
| 424B5 | Prospectus supplement | Jul 14, 2023 | — |
| 424B4 | Prospectus | Sep 21, 2022 | — |
| FWP | Free writing prospectus | Sep 19, 2022 | — |
| 424B4 | Prospectus | Sep 19, 2022 | — |
| S-8 | Employee stock plan registration | Jun 22, 2022 | — |
| S-3 | Shelf registration | Mar 18, 2022 | — |
| S-8 | Employee stock plan registration | Dec 21, 2020 | — |
| 424B4 | Prospectus | Dec 18, 2020 | — |
| S-1/A | Amended registration statement | Dec 1, 2020 | — |
| FWP | Free writing prospectus | Nov 25, 2020 | — |
| S-1/A | Amended registration statement | Nov 12, 2020 | — |
| S-1/A | Amended registration statement | Oct 23, 2020 | — |
| FWP | Free writing prospectus | Oct 16, 2020 | — |
| S-1/A | Amended registration statement | Oct 16, 2020 | — |
| S-1/A | Amended registration statement | Oct 2, 2020 | — |
| S-1/A | Amended registration statement | Sep 25, 2020 | — |
| S-1/A | Amended registration statement | Sep 16, 2020 | — |
| S-1 | Registration statement | Aug 28, 2020 | — |
Showing 30 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- DWTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Alpharetta, GA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1818844
- Former names
- Virios Therapeutics, Inc. (until Oct 15, 2024); Virios Therapeutics, LLC (until Dec 16, 2020)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.